Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Durso

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2004
CD81 is an entry coreceptor for hepatitis C virusEmmanuel G Cormier, Fay Tsamis, Francis Kajumo, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2003
L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virusJason P Gardner, Robert J Durso, Robert R Arrigale, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 2004
L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virusEmmanuel G Cormier, Robert J Durso, Fotini Tsamis, et al.
Virology|May 5, 2009
Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivoKaustuv Banerjee, Sofija Andjelic, Per Johan Klasse, et al.
The Journal of General Virology|August 9, 2006
L-SIGN (CD209L) isoforms differently mediate trans-infection of hepatoma cells by hepatitis C virus pseudoparticlesEmilia Falkowska, Robert J Durso, Jason P Gardner, et al.
Cytometry. Part B, Clinical Cytometry|September 15, 2025
Ad hoc antibody modification of a validated flow cytometric immunophenotyping panel-recommendations and safeguards for clinical laboratoriesChristopher J Groves, Michael A Linden, Ahmad Al-Attar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
A novel alphavirus vaccine encoding prostate-specific membrane antigen elicits potent cellular and humoral immune responsesRobert J Durso, Sofija Andjelic, Jason P Gardner, et al.
Vaccine|July 2, 2009
Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1Yun Kenneth Kang, Sofija Andjelic, James M Binley, et al.
Cytometry. Part B, Clinical Cytometry|August 21, 2024
Flow cytometry assay modifications: Recommendations for method validation based on CLSI H62 guidelinesSara A Monaghan, Steven Eck, Silvia Bunting, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2004
CD81 is an entry coreceptor for hepatitis C virusEmmanuel G Cormier, Fay Tsamis, Francis Kajumo, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2003
L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virusJason P Gardner, Robert J Durso, Robert R Arrigale, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 2004
L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virusEmmanuel G Cormier, Robert J Durso, Fotini Tsamis, et al.
Virology|May 5, 2009
Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivoKaustuv Banerjee, Sofija Andjelic, Per Johan Klasse, et al.
The Journal of General Virology|August 9, 2006
L-SIGN (CD209L) isoforms differently mediate trans-infection of hepatoma cells by hepatitis C virus pseudoparticlesEmilia Falkowska, Robert J Durso, Jason P Gardner, et al.
Cytometry. Part B, Clinical Cytometry|September 15, 2025
Ad hoc antibody modification of a validated flow cytometric immunophenotyping panel-recommendations and safeguards for clinical laboratoriesChristopher J Groves, Michael A Linden, Ahmad Al-Attar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
A novel alphavirus vaccine encoding prostate-specific membrane antigen elicits potent cellular and humoral immune responsesRobert J Durso, Sofija Andjelic, Jason P Gardner, et al.
Vaccine|July 2, 2009
Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1Yun Kenneth Kang, Sofija Andjelic, James M Binley, et al.
Cytometry. Part B, Clinical Cytometry|August 21, 2024
Flow cytometry assay modifications: Recommendations for method validation based on CLSI H62 guidelinesSara A Monaghan, Steven Eck, Silvia Bunting, et al.
Pageof 1